Numeric Investors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
SCM
Numeric Investors's EBS Position: Q4 2017 in Review
Numeric Investors increased its Emergent Biosolutions (EBS) stake by 1,171% in Q4 2017, buying an estimated $4.88M and bringing the position to 125,800 shares worth $5.85M. The position accounts for 0.04% of the portfolio, ranked #387.
Numeric Investors first reported a position in EBS in Q2 2013 and has held it in 14 quarters since. The position peaked at $15.6M in Q1 2014. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.
- Numeric Investors held 125,800 shares of Emergent Biosolutions worth $5.85M as of Q4 2017.
- Numeric Investors bought 115,900 Emergent Biosolutions shares in Q4 2017, an estimated $4.88M.
- Emergent Biosolutions made up 0.04% of Numeric Investors's portfolio in Q4 2017, its #387 holding.
- Numeric Investors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 14 quarters since.
- Numeric Investors's Emergent Biosolutions position peaked at $15.6M in Q1 2014.
- 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.
Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.